Unistar Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 15-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 15-11-2024
- Company Age 14 Year, 18 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.38 M
as on 15-11-2024
- Revenue 22.65%
(FY 2023)
- Profit 12.81%
(FY 2023)
- Ebitda 3.03%
(FY 2023)
- Net Worth 12.75%
(FY 2023)
- Total Assets 41.21%
(FY 2023)
About Unistar Biotech
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹7.38 M.
Sanjay Kumar, Yogendra Kumar, Aseem Kumar, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2010PLC063156
- Company No.
063156
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Unistar Biotech?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogendra Kumar  | Director | 06-Dec-2010 | Current |
| Randhir Singh | Director | 04-May-2012 | Current |
| Aseem Kumar | Director | 06-Dec-2010 | Current |
| Sanjay Kumar | Director | 06-Dec-2010 | Current |
| Manish Kumar | Director | 04-May-2012 | Current |
| Prakash Chandra | Director | 04-May-2012 | Current |
Financial Performance of Unistar Biotech.
Unistar Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.65% increase. The company also saw a substantial improvement in profitability, with a 12.81% increase in profit. The company's net worth Soared by an impressive increase of 12.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unistar Biotech?
In 2023, Unistar Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Solvate Laboratories Private LimitedActive 20 years 5 monthsSanjay Kumar, Yogendra Kumar and 1 more are mutual person
Quasar Labs Private LimitedActive 19 years 5 monthsSanjay Kumar, Yogendra Kumar and 1 more are mutual person
Soltech Infra Private LimitedActive 10 years 8 monthsSanjay Kumar, Yogendra Kumar and 1 more are mutual person
- G&K Building Material Online LlpActive 9 years 9 months
Yogendra Kumar and Aseem Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Oct 2022 | ₹1.20 M | Open |
Hdfc Bank Limited Creation Date: 28 Sep 2022 | ₹2.64 M | Open |
Hdfc Bank Limited Creation Date: 13 Nov 2020 | ₹3.54 M | Open |
How Many Employees Work at Unistar Biotech?
Unlock and access historical data on people associated with Unistar Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unistar Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unistar Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
